Cargando…

Incidence of Myocarditis after Messenger RNA Vaccine for COVID-19 in Young Male Recipients

Detalles Bibliográficos
Autores principales:	Kato, Shingo, Horita, Nobuyuki, Utsunomiya, Daisuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941529/ https://www.ncbi.nlm.nih.gov/pubmed/35339272 http://dx.doi.org/10.1016/j.amjcard.2022.02.010

Ejemplares similares

Imaging characteristics of myocarditis after mRNA‐based COVID‐19 vaccination: a meta‐analysis
por: Kato, Shingo, et al.
Publicado: (2022)

A population-based assessment of myocarditis after messenger RNA COVID-19 booster vaccination among adult recipients
por: Naveed, Zaeema, et al.
Publicado: (2023)

Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine
por: Wang, Mingwei, et al.
Publicado: (2022)

Sodium‐glucose cotransporter 2 inhibitors in heart failure with chronic kidney disease
por: Kato, Shingo, et al.
Publicado: (2022)

Cardiac magnetic resonance-derived tissue tracking strain in patients with hypertrophic cardiomyopathy
por: Kato, Shingo, et al.
Publicado: (2022)

Sodium-glucose cotransporter 2 inhibitors in obese patients with heart failure
por: Kato, Shingo, et al.
Publicado: (2023)

Sodium-glucose cotransporter 2 inhibitors in Asian patients with heart failure
por: Kato, Shingo, et al.
Publicado: (2023)

Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series
por: Murakami, Yoshiki, et al.
Publicado: (2021)

Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines
por: Le Vu, Stéphane, et al.
Publicado: (2022)

Overlapping Myocarditis and Postural Orthostatic Tachycardia Syndrome After COVID-19 Messenger RNA Vaccination: A Case Report
por: Sanada, Yuichi, et al.
Publicado: (2022)

Coronary flow reserve evaluated by phase-contrast cine cardiovascular magnetic resonance imaging of coronary sinus: a meta-analysis
por: Tanigaki, Toshiki, et al.
Publicado: (2023)

Fulminant Myocarditis 24 Days after Coronavirus Disease Messenger Ribonucleic Acid Vaccination
por: Kawano, Hiroaki, et al.
Publicado: (2022)

Antibody response to the messenger RNA‐1273 vaccine (Moderna) in liver transplant recipients
por: Cuadrado, Antonio, et al.
Publicado: (2022)

Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination—A nationwide study
por: Su, Wei-Ju, et al.
Publicado: (2023)

Effectiveness of Messenger Ribonucleic Acid Vaccine in Lung Transplant Recipients
por: Vender, R.J., et al.
Publicado: (2022)

Two Cases of Acute Myocarditis in Young Male Adults After mRNA Vaccines Against COVID-19: Similarities and Differences
por: Sdogkos, Evangelos, et al.
Publicado: (2022)

Diagnostic accuracy of whole heart coronary magnetic resonance angiography: a systematic review and meta-analysis
por: Kato, Shingo, et al.
Publicado: (2023)

COVID‐19 vaccine induced myocarditis in young males: A systematic review
por: Knudsen, Benjamin, et al.
Publicado: (2023)

Antibody response to the messenger RNA corona virus disease 2019 vaccine in liver transplant recipients
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Multidisciplinary diagnostic approach for fulminant myocarditis related to coronavirus disease 2019 messenger RNA vaccines: a case report
por: Fujii, Masayoshi, et al.
Publicado: (2023)

Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation
por: Lim, Yongwhan, et al.
Publicado: (2021)

Younger males at greatest risk of myocarditis after mRNA-based COVID-19 vaccination
Publicado: (2022)

HIV and Messenger RNA (mRNA) Vaccine
por: Khalid, Khizer, et al.
Publicado: (2021)

Risk of Coronavirus Disease 2019 Messenger RNA Vaccination-Associated Myocarditis and Pericarditis – A Systematic Review of Population-Based Data
por: Lin, Yen-Ching, et al.
Publicado: (2023)

Acute interstitial nephritis after messenger RNA-based vaccination
por: Czerlau, Cecilia, et al.
Publicado: (2021)

Sustained Myocarditis following Messenger RNA Vaccination against Coronavirus Disease 2019: Relation to Neutralizing Antibody and Amelioration by Low-Dose Booster Vaccination
por: Miyazaki, Koji, et al.
Publicado: (2023)

Myocarditis after Covid-19 mRNA Vaccination
por: Verma, Amanda K., et al.
Publicado: (2021)

SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients
por: Hallett, Andrew M., et al.
Publicado: (2021)

Myocarditis after RNA-based vaccines for coronavirus.
por: Cordero, Alberto, et al.
Publicado: (2022)

Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination Compared With Viral Myocarditis
por: Lai, Francisco Tsz Tsun, et al.
Publicado: (2022)

Systemic Lupus Induced by Messenger RNA Vaccination
por: Voisin, Olivier, et al.
Publicado: (2022)

Myocarditis rare after COVID-19 mRNA vaccination
Publicado: (2021)

Hypersensitivity Myocarditis after COVID-19 mRNA Vaccination
por: Frustaci, Andrea, et al.
Publicado: (2022)

Myocarditis after COVID‐19 mRNA vaccination in Australia
por: Varma, Suraj K, et al.
Publicado: (2022)

Branch Retinal Vein Occlusion after Messenger RNA-Based COVID-19 Vaccine
por: Sugihara, Kazunobu, et al.
Publicado: (2022)

Acute Lymphocytic Myocarditis in a Young Male Post-COVID-19
por: Bohné, Mintje, et al.
Publicado: (2023)

Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients
por: Hajjo, Rima, et al.
Publicado: (2021)

Assessment of 4 Doses of SARS-CoV-2 Messenger RNA–Based Vaccine in Recipients of a Solid Organ Transplant
por: Kamar, Nassim, et al.
Publicado: (2021)

Recurrent lymphocytic myocarditis in a young male with ulcerative colitis
por: Varnavas, Varnavas C, et al.
Publicado: (2014)

A Young Male with Severe Myocarditis and Skeletal Muscle Myositis
por: Ibrahim, Abdalla, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o6iruabqnckeg381u7j40m730j